Cough, Cold and Allergy (Hay Fever) Remedies in China - New Market Research Report

Value growth of cough, cold and allergy (hay fever) remedies (CCA) stabilised in 2014, at 8%, after a series of product safety issues since 2012. Firstly, ephedrine, one of the illegal drug making elements, was discovered in multinational CCA brands, such as New Contac and White & Black in 2012. Secondly, amantadine, hazardous to children’s livers and kidneys, was found in paediatric CCA products in late 2012, with domestic brands, such as Hu Tong from Harbin Pharmaceutical Group Co Ltd, affected. These incidents have led to the impaired confidence among consumers in their self-medication for colds and coughs.

Competitive Landscape

CR Sanjiu Medical & Pharmaceutical Co Ltd continued to lead with a value share of 10% in 2014. Its flagship brand, 999, consolidated its leadership in the category thanks to its age-specific product ranges targeting children and adults separately, as well as varied product formats, in granules and capsules, to meet various consumer needs. Its product efficacy has been strengthened via its herbal ingredient-based formula with added western active pharmaceutical ingredients. In addition, its effective marketing, via TV programme sponsorship, has managed to further enhance its brand awareness across the country.

Full Report Details at
- http://www.fastmr.com/prod/974587_cough_cold_and_allergy_hay_fever_remedies_in.aspx?afid=301

Industry Prospects

CCA is expected to experience a steady value CAGR of 5% at constant 2014 prices in the forecast period, to be underpinned by the stable demand from the widely present self-medication for common colds and coughs among local consumers. With a quickened life pace, time-pressed modern consumers are more likely to treat the mild symptoms of coughs and colds by themselves, leading to steady demand over the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in China with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in China, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in China market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cough, Cold and Allergy (Hay Fever) Remedies in Romania
- Cough, Cold and Allergy (Hay Fever) Remedies in Germany
- Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in Portugal